This HTML5 document contains 68 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n18http://linked.opendata.cz/resource/drugbank/drug/DB00345/identifier/chemspider/
n20http://linked.opendata.cz/resource/drugbank/company/
foafhttp://xmlns.com/foaf/0.1/
n7http://linked.opendata.cz/resource/drugbank/dosage/
n24http://linked.opendata.cz/resource/drugbank/drug/DB00345/identifier/wikipedia/
n22http://bio2rdf.org/drugbank:
n23http://linked.opendata.cz/resource/drugbank/drug/DB00345/identifier/pharmgkb/
admshttp://www.w3.org/ns/adms#
n16http://linked.opendata.cz/resource/drugbank/drug/DB00345/identifier/pubchem-compound/
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n21http://linked.opendata.cz/resource/drugbank/medicinal-product/
n17http://linked.opendata.cz/resource/drugbank/drug/DB00345/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/resource/drugbank/drug/DB00345/identifier/kegg-drug/
n6http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB00345/identifier/drugbank/
n4http://www.rxlist.com/cgi/generic2/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB00345/identifier/national-drug-code-directory/
n9http://linked.opendata.cz/resource/atc/
n8http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB00345
rdf:type
n5:Drug
n5:description
The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity. [PubChem]
n5:dosage
n7:271B5C86-363D-11E5-9242-09173F13E4C5
n5:group
approved
n5:indication
Used to measure effective renal plasma flow (ERPF) and to determine the functional capacity of the tubular excretory mechanism.
n5:manufacturer
n20:271B5C84-363D-11E5-9242-09173F13E4C5
owl:sameAs
n15:DB00345 n22:DB00345
dcterms:title
Aminohippurate
adms:identifier
n11:D01421 n12:0006-3395-11 n13:DB00345 n16:2148 n17:46507106 n18:2063 n23:PA134711723 n24:Para-Aminohippurate
n5:mechanismOfAction
Aminohippurate is filtered by the renal glomeruli and secreted into the urine by the proximal tubules. By measuring the amount of drug in the urine it is possible to determine functional capacity and effective renal plasma flow.
n5:packager
n20:271B5C83-363D-11E5-9242-09173F13E4C5
n5:synonym
Aminohippuric acid para-aminohippurate N-(P-Aminobenzoyl)aminoacetic acid para-aminohippuric acid P-Aminohippurate 4-Aminohippuric acid Paraaminohippuric acid Paha N-(P-Aminobenzoyl)glycine N-(Para-aminobenzoyl)glycine PAH
n5:toxicity
The intravenous LD<sub>50</sub> in female mice is 7.22 g/kg.
n5:salt
foaf:page
n4:aminohippurate.htm
n5:IUPAC-Name
n6:271B5C8B-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5C91-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5C90-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5C8D-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5C8E-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5C8F-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5CA1-363D-11E5-9242-09173F13E4C5 n6:271B5C89-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5CA3-363D-11E5-9242-09173F13E4C5 n6:271B5C8A-363D-11E5-9242-09173F13E4C5 n6:271B5C87-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5C88-363D-11E5-9242-09173F13E4C5
n5:pKa
n6:271B5CA4-363D-11E5-9242-09173F13E4C5
n8:hasATCCode
n9:V04CH30
n5:H-Bond-Acceptor-Count
n6:271B5C97-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5C98-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5C92-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5C93-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5C95-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5C94-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5C96-363D-11E5-9242-09173F13E4C5
n5:affectedOrganism
Humans and other mammals
n5:casRegistryNumber
94-16-6
n5:category
n5:containedIn
n21:271B5C85-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5C9D-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5C9F-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5CA0-363D-11E5-9242-09173F13E4C5
n5:Melting-Point
n6:271B5CA2-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5C9C-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5C9B-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5C9E-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5C8C-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5C99-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5C9A-363D-11E5-9242-09173F13E4C5